# Valproate Versus Propranolol in Migraine

> **NCT06485726** · PHASE4 · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 600 (estimated)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Valproic Acid 500 MG
- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT06485726
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-23
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-05
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485726, "Valproate Versus Propranolol in Migraine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06485726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*